Cargando…

Increased Inflammation in Atherosclerotic Lesions of Diabetic Akita-LDLr (−/−) Mice Compared to Nondiabetic LDLr (−/−) Mice

Background. Diabetes is associated with increased cardiovascular disease, but the underlying cellular and molecular mechanisms are poorly understood. One proposed mechanism is that diabetes aggravates atherosclerosis by enhancing plaque inflammation. The Akita mouse has recently been adopted as a re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Engelbertsen, Daniel, To, Fong, Dunér, Pontus, Kotova, Olga, Söderberg, Ingrid, Alm, Ragnar, Gomez, Maria F., Nilsson, Jan, Bengtsson, Eva
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3515907/ https://www.ncbi.nlm.nih.gov/pubmed/23243415 http://dx.doi.org/10.1155/2012/176162

Ejemplares similares

Deficiency of CCAAT/Enhancer Binding Protein-Epsilon Reduces Atherosclerotic Lesions in LDLR−/− Mice
por: Okamoto, Ryoko, et al.
Publicado: (2014)

Cardiotonic Pills Plus Recombinant Human Prourokinase Ameliorates Atherosclerotic Lesions in LDLR(–/–) Mice
por: Deng, Jing-Na, et al.
Publicado: (2019)

Stimulation of the PD-1 Pathway Decreases Atherosclerotic Lesion Development in Ldlr Deficient Mice
por: Grievink, Hendrika W., et al.
Publicado: (2021)

IL-25 Inhibits Atherosclerosis Development in Apolipoprotein E Deficient Mice
por: Mantani, Polyxeni T., et al.
Publicado: (2015)

Hyperlipidemia and Atherosclerotic Lesion Development in Ldlr-Deficient Mice on a Long-Term High-Fat Diet
por: Ma, Yanling, et al.
Publicado: (2012)

Agonistic Anti-TIGIT Treatment Inhibits T Cell Responses in LDLr Deficient Mice without Affecting Atherosclerotic Lesion Development
por: Foks, Amanda C., et al.
Publicado: (2013)

T Cells in Atherosclerosis in Ldlr−/− and Apoe−/− Mice
por: Getz, Godfrey S., et al.
Publicado: (2018)

Uptake of (68)gallium in atherosclerotic plaques in LDLR(-/-)ApoB(100/100 )mice
por: Silvola, Johanna MU, et al.
Publicado: (2011)

HVC1 ameliorates hyperlipidemia and inflammation in LDLR(−/−) mice
por: Cheon, Se-Yun, et al.
Publicado: (2017)

Serum Amyloid A Facilitates Early Lesion Development in Ldlr(−/−) Mice
por: Krishack, Paulette A, et al.
Publicado: (2015)

Oxidative Stress and Lipid Accumulation Augments Cell Death in LDLR-Deficient RPE Cells and Ldlr (−/−) Mice
por: Sreekumar, Parameswaran Gangadharan, et al.
Publicado: (2022)

Berberine decreases plasma triglyceride levels and upregulates hepatic TRIB1 in LDLR wild type mice and in LDLR deficient mice
por: Singh, Amar Bahadur, et al.
Publicado: (2019)

Worsening of Oxidative Stress, DNA Damage, and Atherosclerotic Lesions in Aged LDLr(−/−) Mice after Consumption of Guarana Soft Drinks
por: Chisté, Layla Aparecida, et al.
Publicado: (2019)

In vivo inhibition of nuclear factor of activated T-cells leads to atherosclerotic plaque regression in IGF-II/LDLR(–/–)ApoB(100/100) mice
por: Blanco, Fabiana, et al.
Publicado: (2018)

Deficiency of Adipocyte IKKβ Affects Atherosclerotic Plaque Vulnerability in Obese LDLR Deficient Mice
por: Lu, Weiwei, et al.
Publicado: (2019)

Dietary Cholesterol Is Highly Associated with Severity of Hyperlipidemia and Atherosclerotic Lesions in Heterozygous LDLR-Deficient Hamsters
por: Wang, Jinjie, et al.
Publicado: (2019)

Blockade of the BLT1-LTB(4) axis does not affect mast cell migration towards advanced atherosclerotic lesions in LDLr(−/−) mice
por: Depuydt, Marie A. C., et al.
Publicado: (2022)

Pharmacological Treatment with Annexin A1 Reduces Atherosclerotic Plaque Burden in LDLR(-/-) Mice on Western Type Diet
por: Kusters, Dennis H. M., et al.
Publicado: (2015)

Impact of atherosclerotic disease on cerebral microvasculature and tissue oxygenation in awake LDLR−/−hApoB+/+ transgenic mice
por: Lu, Yuankang, et al.
Publicado: (2019)

Deletion of Macrophage-Specific Glycogen Synthase Kinase (GSK)-3α Promotes Atherosclerotic Regression in Ldlr(−/−) Mice
por: Patel, Sarvatit, et al.
Publicado: (2022)

Pravastatin and Sarpogrelate Synergistically Ameliorate Atherosclerosis in LDLr-Knockout Mice
por: Park, Kyung-Yeon, et al.
Publicado: (2016)

Is Western Diet-Induced Nonalcoholic Steatohepatitis in Ldlr(-/-) Mice Reversible?
por: Lytle, Kelli A., et al.
Publicado: (2016)

Poloxamer 407 Induces Hypertriglyceridemia but Decreases Atherosclerosis in Ldlr(−/−) Mice
por: Peng, Xueying, et al.
Publicado: (2022)

The Beneficial Effect of Lomitapide on the Cardiovascular System in LDLr(−/−) Mice with Obesity
por: Munkhsaikhan, Undral, et al.
Publicado: (2023)

Atherogenesis in Apoe(−/−) and Ldlr(−/−) Mice with a Genetically Resistant Background
por: Torikai, Hideyuki, et al.
Publicado: (2023)

Vitamin D(3) supplementation of a high fat high sugar diet ameliorates prediabetic phenotype in female LDLR(−/−) and LDLR(+/+) mice
por: Kheder, Ramiar, et al.
Publicado: (2017)

ILC2 transfers to apolipoprotein E deficient mice reduce the lipid content of atherosclerotic lesions
por: Mantani, Polyxeni T., et al.
Publicado: (2019)

Genetic Disruption of Myostatin Reduces the Development of Proatherogenic Dyslipidemia and Atherogenic Lesions In Ldlr Null Mice
por: Tu, Powen, et al.
Publicado: (2009)

Triciribine increases LDLR expression and LDL uptake through stabilization of LDLR mRNA
por: Bjune, Katrine, et al.
Publicado: (2018)

MLb-LDLr: A Machine Learning Model for Predicting the Pathogenicity of LDLr Missense Variants
por: Larrea-Sebal, Asier, et al.
Publicado: (2021)

Liraglutide Reduces Both Atherosclerosis and Kidney Inflammation in Moderately Uremic LDLr-/- Mice
por: Bisgaard, Line S., et al.
Publicado: (2016)

Macrophage deficiency of Akt2 reduces atherosclerosis in Ldlr null mice
por: Babaev, Vladimir R., et al.
Publicado: (2014)

Therapeutic silencing of FSP27 reduces the progression of atherosclerosis in Ldlr(−/−) mice
por: Rajamoorthi, Ananthi, et al.
Publicado: (2018)

Tanshinone IIA alleviates atherosclerosis in LDLR(−/−) mice by regulating efferocytosis of macrophages
por: Wang, Jiarou, et al.
Publicado: (2023)

Prodigiosin Modulates the Immune Response and Could Promote a Stable Atherosclerotic Lession in C57bl/6 Ldlr-/- Mice
por: Cuevas, Alejandro, et al.
Publicado: (2020)

Different Susceptibilities between Apoe- and Ldlr-Deficient Mice to Inflammation-Associated Colorectal Carcinogenesis
por: Tanaka, Takuji, et al.
Publicado: (2016)

The enigma of soluble LDLR: could inflammation be the key?
por: Mbikay, Majambu, et al.
Publicado: (2020)

Dystrophin deficiency reduces atherosclerotic plaque development in ApoE-null mice
por: Shami, Annelie, et al.
Publicado: (2015)

Scavenging of reactive dicarbonyls with 2-hydroxybenzylamine reduces atherosclerosis in hypercholesterolemic Ldlr(−/−) mice
por: Tao, Huan, et al.
Publicado: (2020)

Semaglutide Has Beneficial Effects on Non-Alcoholic Steatohepatitis in Ldlr-/-.Leiden Mice
por: Inia, José A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7ojv726kepdpt9sc29r5jov69s